Company
United StatesPublic company, NYSE: AIMAIM ImmunoTech Inc (NYSE: AIM), North Brunswick, NJ – FDA Inspections
Inspection records and compliance data for AIM ImmunoTech Inc in North Brunswick, New Jersey. 3 FDA inspections on record, last inspected January 05, 2017. Publicly traded as NYSE: AIM.
Company Profile
This profile covers AIM ImmunoTech Inc based in North Brunswick, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 1
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected June 22, 2010. Last inspected January 5, 2017.
Most cited issue areas
- General responsibilities of sponsors1 inspection
- Investigator non-compliance1 inspection
- Records of Financial Interests1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 5, 2017 | NAI | Human Drugs · Drug Quality Assurance | 997338 |
| November 9, 2012 | VAI | Human Drugs · Bioresearch Monitoring | 807004 |
| June 22, 2010 | NAI | Human Drugs · Drug Quality Assurance | 667908 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
AIM ImmunoTech Inc
Stock ticker
AIM
Exchange
NYSE
Share price
$0.15
Market cap
$6.1M
Price as of
November 6, 2026
FEI Number
2243819
Address
671 Us Highway 1 Ste A, North Brunswick, New Jersey 08902, United States
Country
United States
ID: b89e884e-a1a5-4eb3-96fd-080d4a0ce07a